Reaction
Pelvic Mass reporting signals
As of the last recalculation, Pelvic Mass appears in 797 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is NYSTATIN OINTMENT (PRR 27.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nystatin Ointment | 27 | 27.8 | 27.8 |
| Nystatin Cream | 27 | 27.8 | 27.8 |
| Rucaparib | 9 | 26.9 | 26.9 |
| Nystatin | 27 | 26.7 | 26.7 |
| Niraparib | 21 | 25.4 | 25.4 |
| Anastrozole Tablets | 16 | 19.9 | 19.9 |
| Polatuzumab Vedotin | 6 | 16.2 | 16.2 |
| Olaparib | 12 | 15.2 | 15.2 |
| Leuprolide Acetate | 33 | 11.5 | 11.6 |
| Avapritinib | 5 | 10.8 | 10.8 |
| Erlotinib | 4 | 10.8 | 10.8 |
| Temozolomide | 8 | 10.0 | 10.0 |
| Trifluridine And Tipiracil | 4 | 9.8 | 9.8 |